Table 4 Ongoing clinical trials of EGF816
From: Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
Phase | Study population | NCT no. |
|---|---|---|
Phase I/II | Patients with EGFR mutated solid malignancies | 02108964 |
Phase Ib/II | Patients with EGFR mutated NSCLC | 02335944 |
Phase II | Patients with EGFR mutated and cMET-positive NSCLC | 02323126 |